CLADRIBINE

CLADRIBINE was reported 9967 times

CLADRIBINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MYELOBLAST PERCENTAGE DECREASED 7 0.5833
1 HAIRY CELL LEUKAEMIA RECURRENT 16 0.3902
2 GASTROINTESTINAL PROTOZOAL INFECTION 10 0.3846
3 HAEMANGIOMA OF SPLEEN 9 0.1452
4 LIVER PALPABLE 8 0.1127
5 ERYTHROLEUKAEMIA 7 0.0921
6 PURTSCHER RETINOPATHY 7 0.0854
7 HAIRY CELL LEUKAEMIA 19 0.0815
8 T-CELL PROLYMPHOCYTIC LEUKAEMIA 7 0.0753
9 REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA 6 0.0588
10 LEUKAEMIA CUTIS 9 0.0584
11 STOMATOCOCCAL INFECTION 7 0.0565
12 BRAF GENE MUTATION 5 0.0556
13 ABDOMINAL WALL WOUND 8 0.0519
14 MULTIPLE SCLEROSIS PSEUDO RELAPSE 17 0.0501
15 GASTROINTESTINAL MUCORMYCOSIS 7 0.0419
16 AUTOIMMUNE THROMBOCYTOPENIA 18 0.0416
17 CHRONIC LYMPHOCYTIC LEUKAEMIA TRANSFORMATION 7 0.0335
18 SYSTEMIC MASTOCYTOSIS 10 0.0332
19 AUTOINFLAMMATORY DISEASE 7 0.0330
20 GASTROENTERITIS STAPHYLOCOCCAL 5 0.0318
21 GASTROINTESTINAL LYMPHOMA 8 0.0308
22 OVERGROWTH BACTERIAL 8 0.0297
23 INTERCEPTED PRODUCT PRESCRIBING ERROR 38 0.0287
24 LYMPHOCYTE COUNT DECREASED 507 0.0287
25 CLOSTRIDIUM BACTERAEMIA 6 0.0280
26 ANAEMIA HAEMOLYTIC AUTOIMMUNE 22 0.0266
27 CONGENITAL APLASIA 8 0.0257
28 OESTRADIOL INCREASED 7 0.0233
29 PATERNAL EXPOSURE BEFORE PREGNANCY 7 0.0230
30 HEMIHYPOAESTHESIA 8 0.0228
31 PROGESTERONE DECREASED 7 0.0225
32 GENITAL ABSCESS 8 0.0198
33 RELAPSING-REMITTING MULTIPLE SCLEROSIS 16 0.0185
34 LYMPHOPENIA 238 0.0168
35 DYSPLASTIC NAEVUS 6 0.0166
36 TRICHOSPORON INFECTION 6 0.0148
37 HYPERSPLENISM 7 0.0141
38 ACUTE MYELOID LEUKAEMIA RECURRENT 30 0.0140
39 JC POLYOMAVIRUS TEST POSITIVE 16 0.0137
40 MATERNAL EXPOSURE BEFORE PREGNANCY 93 0.0136
41 PNEUMATOSIS 6 0.0135
42 EXPANDED DISABILITY STATUS SCALE SCORE INCREASED 16 0.0128
43 ASYMPTOMATIC COVID-19 5 0.0127
44 GROWTH HORMONE DEFICIENCY 5 0.0126
45 GRAFT VERSUS HOST DISEASE IN LUNG 6 0.0126
46 NONINFECTIVE ENCEPHALITIS 9 0.0125
47 MATERNAL EXPOSURE TIMING UNSPECIFIED 46 0.0122
48 LACRIMAL DISORDER 7 0.0120
49 BLOOD OESTROGEN INCREASED 7 0.0119
50 ANGULAR CHEILITIS 8 0.0116
51 BRADYARRHYTHMIA 19 0.0116
52 SACRAL PAIN 7 0.0115
53 PEPTIC ULCER HAEMORRHAGE 8 0.0115
54 RESPIRATORY TRACT INFECTION FUNGAL 6 0.0114
55 GINGIVAL ABSCESS 8 0.0106
56 COMPLICATION OF PREGNANCY 8 0.0105
57 T-LYMPHOCYTE COUNT DECREASED 7 0.0103
58 LEUKAEMIA RECURRENT 17 0.0100
59 MAGNETIC RESONANCE IMAGING ABNORMAL 12 0.0100
60 EXPOSURE TO SARS-COV-2 15 0.0088
61 SINUSITIS FUNGAL 7 0.0087
62 BAND SENSATION 11 0.0087
63 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 7 0.0086
64 PERIORBITAL HAEMATOMA 7 0.0085
65 MONOCYTE COUNT DECREASED 10 0.0082
66 B-LYMPHOCYTE COUNT DECREASED 11 0.0081
67 BLOOD IMMUNOGLOBULIN A DECREASED 5 0.0077
68 PNEUMONIA INFLUENZAL 9 0.0076
69 MULTIPLE SCLEROSIS RELAPSE 494 0.0072
70 FACIAL DISCOMFORT 5 0.0071
71 GRAFT VERSUS HOST DISEASE IN LIVER 5 0.0070
72 ENDOCRINE OPHTHALMOPATHY 6 0.0069
73 LIP INJURY 9 0.0069
74 SYSTEMIC MYCOSIS 8 0.0068
75 BLADDER DYSFUNCTION 7 0.0068
76 HYPERLEUKOCYTOSIS 6 0.0068
77 LYMPHOCYTE PERCENTAGE DECREASED 9 0.0067
78 BONE NEOPLASM 7 0.0065
79 CUTANEOUS VASCULITIS 23 0.0063
80 VERTIGO POSITIONAL 11 0.0063
81 ENTEROCOCCAL SEPSIS 5 0.0062
82 ASPERGILLOSIS 8 0.0061
83 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 13 0.0061
84 GASTROINTESTINAL WALL THICKENING 9 0.0060
85 SPLEEN DISORDER 10 0.0059
86 INFECTED CYST 7 0.0058
87 PERTUSSIS 6 0.0057
88 MEGACOLON 9 0.0057
89 MYELODYSPLASTIC SYNDROME 82 0.0057
90 MULTIPLE SCLEROSIS 270 0.0056
91 ANOGENITAL WARTS 5 0.0056
92 NEUTROPHIL PERCENTAGE INCREASED 7 0.0055
93 NOROVIRUS INFECTION 8 0.0055
94 BLADDER CATHETERISATION 5 0.0052
95 STENOTROPHOMONAS INFECTION 7 0.0052
96 INVASIVE DUCTAL BREAST CARCINOMA 14 0.0051
97 ABORTION 15 0.0051
98 STREPTOCOCCAL SEPSIS 6 0.0051
99 ATYPICAL PNEUMONIA 15 0.0050
100 DECREASED IMMUNE RESPONSIVENESS 48 0.0049
101 BLOOD IMMUNOGLOBULIN G DECREASED 12 0.0048
102 STEM CELL TRANSPLANT 12 0.0048
103 HUMAN HERPESVIRUS 6 INFECTION 9 0.0048
104 ENTEROCOCCAL BACTERAEMIA 5 0.0047
105 CERVICAL DYSPLASIA 10 0.0046
106 GASTROINTESTINAL TOXICITY 22 0.0046
107 OPHTHALMIC HERPES ZOSTER 8 0.0044
108 OPTIC NEURITIS 40 0.0044
109 JC VIRUS INFECTION 7 0.0044
110 MENINGITIS VIRAL 6 0.0044
111 ACUTE LEUKAEMIA 7 0.0043
112 NEUROGENIC BLADDER 9 0.0043
113 SMEAR CERVIX ABNORMAL 6 0.0042
114 RASH MACULO-PAPULAR 94 0.0042
115 HAEMATOTOXICITY 40 0.0042
116 ESCHERICHIA SEPSIS 12 0.0041
117 ADENOVIRUS INFECTION 12 0.0041
118 PANCREATIC ENZYMES INCREASED 6 0.0041
119 LIVE BIRTH 34 0.0041
120 MENTAL FATIGUE 6 0.0040
121 COVID-19 PNEUMONIA 47 0.0040
122 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 11 0.0040
123 SMALL CELL LUNG CANCER 6 0.0040
124 AUTOIMMUNE THYROIDITIS 15 0.0040
125 FEAR OF DISEASE 7 0.0039
126 LOWER RESPIRATORY TRACT INFECTION 178 0.0039
127 TOXIC SKIN ERUPTION 39 0.0039
128 CYTOMEGALOVIRUS VIRAEMIA 17 0.0038
129 FUNGAEMIA 6 0.0038
130 PNEUMONIA FUNGAL 15 0.0038
131 ADENOCARCINOMA OF COLON 7 0.0037
132 LYMPHOCYTOSIS 8 0.0037
133 ACUTE MYELOID LEUKAEMIA 57 0.0037
134 MEAN CELL HAEMOGLOBIN INCREASED 6 0.0036
135 H1N1 INFLUENZA 5 0.0036
136 GENE MUTATION 7 0.0035
137 NOCARDIOSIS 9 0.0035
138 RETINITIS 6 0.0035
139 VITAMIN B12 DECREASED 10 0.0035
140 TREATMENT DELAYED 6 0.0035
141 WHITE BLOOD CELL COUNT DECREASED 376 0.0035
142 HEPATITIS TOXIC 9 0.0035
143 POSTMENOPAUSAL HAEMORRHAGE 9 0.0034
144 NEUTROPENIC COLITIS 7 0.0034
145 PROTEIN TOTAL INCREASED 9 0.0034
146 HYPERBILIRUBINAEMIA 35 0.0034
147 BRAIN HERNIATION 10 0.0033
148 NORMAL NEWBORN 18 0.0033
149 FEBRILE NEUTROPENIA 218 0.0033
150 B-CELL LYMPHOMA 11 0.0032
151 MYELITIS 5 0.0032
152 LYMPH NODE PAIN 6 0.0032
153 CYSTOID MACULAR OEDEMA 6 0.0032
154 URINARY TRACT INFECTION BACTERIAL 8 0.0032
155 PNEUMONIA VIRAL 10 0.0031
156 THYROID MASS 12 0.0031
157 FINE MOTOR SKILL DYSFUNCTION 9 0.0031
158 COMA SCALE ABNORMAL 9 0.0031
159 ENTEROCOCCAL INFECTION 15 0.0031
160 LISTLESS 10 0.0030
161 SUSPECTED COVID-19 10 0.0030
162 NEUROLOGICAL DECOMPENSATION 7 0.0030
163 URINE ANALYSIS ABNORMAL 9 0.0030
164 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 7 0.0030
165 PANCYTOPENIA 167 0.0030
166 CERVICAL SPINAL STENOSIS 5 0.0029
167 VITREOUS HAEMORRHAGE 8 0.0029
168 PAPILLARY THYROID CANCER 5 0.0029
169 BACTERAEMIA 34 0.0029
170 HAEMATOLOGICAL INFECTION 7 0.0029
171 RETINAL TEAR 7 0.0028
172 CD4 LYMPHOCYTES DECREASED 6 0.0028
173 MONOPARESIS 5 0.0028
174 HYDROCEPHALUS 15 0.0028
175 ABDOMINAL INFECTION 7 0.0027
176 CHRONIC LYMPHOCYTIC LEUKAEMIA 13 0.0027
177 LIMB MASS 6 0.0027
178 HEPATOSPLENOMEGALY 7 0.0027
179 MEAN CELL VOLUME INCREASED 7 0.0027
180 GRAFT VERSUS HOST DISEASE IN SKIN 6 0.0027
181 SUBCUTANEOUS ABSCESS 13 0.0027
182 OPPORTUNISTIC INFECTION 5 0.0027
183 LYME DISEASE 9 0.0027
184 RHINITIS ALLERGIC 12 0.0027
185 BK VIRUS INFECTION 9 0.0027
186 MIXED LIVER INJURY 8 0.0027
187 GRAFT VERSUS HOST DISEASE 19 0.0026
188 IMMUNE THROMBOCYTOPENIA 12 0.0026
189 RED BLOOD CELL SEDIMENTATION RATE INCREASED 29 0.0026
190 ANAL ABSCESS 14 0.0026
191 AGRANULOCYTOSIS 48 0.0026
192 KIDNEY INFECTION 50 0.0025
193 MUSCLE SPASTICITY 31 0.0025
194 INTRACRANIAL PRESSURE INCREASED 14 0.0025
195 IMMUNOSUPPRESSION 22 0.0025
196 HEPATITIS B 15 0.0025
197 BRONCHOPULMONARY ASPERGILLOSIS 19 0.0024
198 TEMPERATURE INTOLERANCE 25 0.0024
199 DYSPNOEA AT REST 7 0.0024
200 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 18 0.0024
201 PNEUMONIA BACTERIAL 22 0.0024
202 RENAL CYST 19 0.0024
203 SYSTEMIC CANDIDA 6 0.0024
204 HERPES ZOSTER 137 0.0024
205 LEUKOPENIA 119 0.0024
206 LABYRINTHITIS 6 0.0024
207 FACE INJURY 9 0.0024
208 HISTIOCYTOSIS HAEMATOPHAGIC 7 0.0024
209 FEBRILE BONE MARROW APLASIA 10 0.0024
210 LUNG ADENOCARCINOMA 7 0.0023
211 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 18 0.0023
212 MUCORMYCOSIS 6 0.0023
213 CERVIX CARCINOMA 9 0.0023
214 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 19 0.0023
215 WOUND SECRETION 9 0.0023
216 EOSINOPHIL COUNT INCREASED 19 0.0023
217 APPENDICECTOMY 8 0.0022
218 CYSTITIS HAEMORRHAGIC 9 0.0022
219 CHRONIC GRAFT VERSUS HOST DISEASE 8 0.0022
220 BONE MARROW FAILURE 45 0.0022
221 DECUBITUS ULCER 18 0.0022
222 HEMIPARESIS 37 0.0022
223 BASAL CELL CARCINOMA 34 0.0022
224 GAMMA-GLUTAMYLTRANSFERASE INCREASED 48 0.0022
225 LOCALISED OEDEMA 10 0.0022
226 BACTERIAL SEPSIS 7 0.0021
227 DISSEMINATED INTRAVASCULAR COAGULATION 30 0.0021
228 ACUTE LYMPHOCYTIC LEUKAEMIA 6 0.0021
229 PERONEAL NERVE PALSY 12 0.0021
230 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 54 0.0021
231 STAPHYLOCOCCAL BACTERAEMIA 9 0.0021
232 UROSEPSIS 19 0.0021
233 LYMPHOPROLIFERATIVE DISORDER 6 0.0020
234 MYELOSUPPRESSION 73 0.0020
235 STAPHYLOCOCCAL SEPSIS 10 0.0020
236 CYST 25 0.0020
237 BONE MARROW DISORDER 6 0.0020
238 ALANINE AMINOTRANSFERASE INCREASED 121 0.0020
239 APPENDICITIS PERFORATED 5 0.0020
240 RETINAL HAEMORRHAGE 14 0.0020
241 DYSCHEZIA 6 0.0020
242 ECTOPIC PREGNANCY 6 0.0019
243 SYNOVIAL CYST 9 0.0019
244 BENIGN PROSTATIC HYPERPLASIA 10 0.0019
245 ASPARTATE AMINOTRANSFERASE INCREASED 101 0.0019
246 ENCEPHALITIS 13 0.0019
247 IMMUNODEFICIENCY 28 0.0019
248 VITAMIN D DECREASED 16 0.0019
249 SENSORY LOSS 15 0.0019
250 ASPERGILLUS INFECTION 12 0.0018
251 BREATH SOUNDS ABNORMAL 9 0.0018
252 MELANOCYTIC NAEVUS 8 0.0018
253 ONYCHOMYCOSIS 8 0.0018
254 ABORTION SPONTANEOUS 73 0.0018
255 NEUTROPENIC SEPSIS 13 0.0018
256 CENTRAL NERVOUS SYSTEM LESION 25 0.0018
257 HYPOTHYROIDISM 58 0.0018
258 CHOLECYSTITIS INFECTIVE 5 0.0018
259 STREPTOCOCCAL INFECTION 10 0.0018
260 NEPHRITIS 6 0.0018
261 NEUTROPHIL COUNT DECREASED 73 0.0018
262 MENISCUS INJURY 11 0.0018
263 LUNG CONSOLIDATION 5 0.0018
264 ELECTRIC SHOCK SENSATION 5 0.0018
265 PRODUCT ADMINISTRATION ERROR 36 0.0018
266 KLEBSIELLA INFECTION 9 0.0018
267 MULTIPLE ORGAN DYSFUNCTION SYNDROME 50 0.0018
268 EPSTEIN-BARR VIRUS INFECTION 11 0.0018
269 PHLEBITIS 9 0.0018
270 CHOLECYSTECTOMY 20 0.0017
271 ACUTE GRAFT VERSUS HOST DISEASE 8 0.0017
272 LEFT VENTRICULAR FAILURE 6 0.0017
273 OESOPHAGITIS 19 0.0017
274 PARAPLEGIA 5 0.0017
275 APLASTIC ANAEMIA 9 0.0017
276 CYTOPENIA 21 0.0017
277 AUTONOMIC NERVOUS SYSTEM IMBALANCE 5 0.0017
278 HANGOVER 6 0.0017
279 VAGINAL INFECTION 8 0.0017
280 DEVICE RELATED INFECTION 26 0.0017
281 URINARY TRACT INFECTION 288 0.0017
282 GESTATIONAL DIABETES 8 0.0017
283 FACE OEDEMA 28 0.0017
284 SEPTIC SHOCK 72 0.0017
285 HYPOKINESIA 24 0.0017
286 MONOCYTE COUNT INCREASED 6 0.0017
287 FACIAL PARALYSIS 14 0.0016
288 PSEUDOMONAS INFECTION 14 0.0016
289 DYSAESTHESIA 5 0.0016
290 DRUG-INDUCED LIVER INJURY 51 0.0016
291 DERMATITIS ALLERGIC 20 0.0016
292 SEPSIS 176 0.0016
293 SENSORY DISTURBANCE 25 0.0016
294 CARDIAC FLUTTER 10 0.0015
295 PULMONARY HAEMORRHAGE 12 0.0015
296 TENDON DISORDER 10 0.0015
297 NEPHROLITHIASIS 70 0.0015
298 VULVOVAGINAL MYCOTIC INFECTION 6 0.0015
299 NEAR DEATH EXPERIENCE 5 0.0015
300 ARTHRITIS INFECTIVE 7 0.0015
301 BRAIN OEDEMA 19 0.0015
302 APPENDICITIS 14 0.0015
303 METASTASES TO SPINE 5 0.0015
304 GALLBLADDER OPERATION 6 0.0015
305 TUMOUR LYSIS SYNDROME 13 0.0015
306 POST PROCEDURAL INFECTION 12 0.0015
307 HEPATIC CYST 5 0.0015
308 APLASIA PURE RED CELL 5 0.0015
309 DEAFNESS UNILATERAL 8 0.0015
310 FUNCTIONAL GASTROINTESTINAL DISORDER 5 0.0014
311 ANAL INCONTINENCE 13 0.0014
312 DERMATITIS EXFOLIATIVE GENERALISED 5 0.0014
313 ORAL HERPES 28 0.0014
314 DYSMENORRHOEA 19 0.0014
315 ATAXIA 17 0.0014
316 SKIN TOXICITY 8 0.0014
317 HYPOALBUMINAEMIA 11 0.0014
318 ESCHERICHIA URINARY TRACT INFECTION 6 0.0014
319 FLUID INTAKE REDUCED 7 0.0014
320 BACTERIAL INFECTION 26 0.0014
321 HEPATIC LESION 6 0.0014
322 THROMBOCYTOPENIA 155 0.0014
323 HYSTERECTOMY 12 0.0014
324 VULVOVAGINAL PRURITUS 7 0.0014
325 STRESS CARDIOMYOPATHY 8 0.0014
326 SKIN WARM 8 0.0014
327 UTERINE LEIOMYOMA 10 0.0014
328 ENDOCARDITIS 7 0.0014
329 CORONAVIRUS INFECTION 9 0.0014
330 BLOOD TEST ABNORMAL 19 0.0014
331 ARTHROPOD BITE 10 0.0013
332 SKIN NECROSIS 7 0.0013
333 HEPATOTOXICITY 30 0.0013
334 CARDIAC DYSFUNCTION 5 0.0013
335 LEUKOENCEPHALOPATHY 5 0.0013
336 TONSILLITIS 7 0.0013
337 DIVERTICULITIS 37 0.0013
338 LYMPHADENOPATHY 47 0.0013
339 BLOOD LACTATE DEHYDROGENASE INCREASED 21 0.0013
340 UPPER RESPIRATORY TRACT INFECTION 61 0.0013
341 NEUTROPENIA 179 0.0013
342 HYPERTHYROIDISM 19 0.0013
343 BEHAVIOUR DISORDER 7 0.0013
344 PNEUMONIA 418 0.0013
345 TOOTH INFECTION 17 0.0013
346 SQUAMOUS CELL CARCINOMA 12 0.0013
347 LEUKAEMIA 12 0.0013
348 PYELONEPHRITIS 11 0.0013
349 MALIGNANT MELANOMA 17 0.0013
350 VIRAL UPPER RESPIRATORY TRACT INFECTION 6 0.0013
351 GINGIVAL PAIN 10 0.0013
352 WHITE BLOOD CELL COUNT ABNORMAL 8 0.0013
353 NON-SMALL CELL LUNG CANCER 6 0.0013
354 SKIN INFECTION 14 0.0012
355 UTERINE CANCER 10 0.0012
356 RHINITIS 10 0.0012
357 CLOSTRIDIUM DIFFICILE INFECTION 27 0.0012
358 HEPATIC STEATOSIS 23 0.0012
359 BALANCE DISORDER 106 0.0012
360 GOITRE 5 0.0012
361 HYPERURICAEMIA 5 0.0012
362 EXOSTOSIS 11 0.0012
363 CYTOMEGALOVIRUS INFECTION 20 0.0012
364 SPLENOMEGALY 14 0.0012
365 NEURALGIA 29 0.0012
366 INTERVERTEBRAL DISC PROTRUSION 26 0.0012
367 HYPERPYREXIA 5 0.0012
368 PLEURISY 7 0.0012
369 MUSCLE TIGHTNESS 19 0.0012
370 NEUTROPHIL COUNT INCREASED 12 0.0012
371 INTERVERTEBRAL DISC DISORDER 5 0.0012
372 GAIT INABILITY 39 0.0012
373 CHOLELITHIASIS 38 0.0012
374 COVID-19 202 0.0012
375 COORDINATION ABNORMAL 16 0.0011
376 POLYARTHRITIS 6 0.0011
377 HEADACHE 713 0.0011
378 GRIP STRENGTH DECREASED 10 0.0011
379 COGNITIVE DISORDER 53 0.0011
380 NYSTAGMUS 6 0.0011
381 BLOOD ALKALINE PHOSPHATASE INCREASED 28 0.0011
382 TRANSAMINASES INCREASED 25 0.0011
383 INFECTION 162 0.0011
384 KNEE OPERATION 11 0.0011
385 NASAL DRYNESS 7 0.0011
386 RESPIRATORY TRACT INFECTION 29 0.0011
387 LIGAMENT SPRAIN 11 0.0011
388 HEAVY MENSTRUAL BLEEDING 10 0.0011
389 OROPHARYNGEAL DISCOMFORT 10 0.0011
390 LIMB DISCOMFORT 34 0.0011
391 BLOOD IRON DECREASED 13 0.0011
392 ESCHERICHIA INFECTION 9 0.0011
393 APHASIA 33 0.0011
394 EAR DISORDER 5 0.0011
395 LUMBAR VERTEBRAL FRACTURE 5 0.0011
396 DYSARTHRIA 41 0.0011
397 FATIGUE 848 0.0011
398 RED BLOOD CELL COUNT DECREASED 31 0.0011
399 HERPES SIMPLEX 7 0.0011
400 HEPATITIS ACUTE 7 0.0011
401 EAR DISCOMFORT 11 0.0011
402 PULMONARY ALVEOLAR HAEMORRHAGE 6 0.0011
403 BEDRIDDEN 14 0.0011
404 DYSGRAPHIA 7 0.0011
405 HEPATIC FAILURE 32 0.0011
406 COLITIS MICROSCOPIC 5 0.0011
407 EAR INFECTION 28 0.0011
408 NEUROLOGICAL SYMPTOM 6 0.0010
409 ENDOMETRIOSIS 5 0.0010
410 MENINGITIS 7 0.0010
411 URINARY INCONTINENCE 31 0.0010
412 HYPOVOLAEMIC SHOCK 5 0.0010
413 HERPES VIRUS INFECTION 6 0.0010
414 LIVER FUNCTION TEST INCREASED 22 0.0010
415 INFARCTION 7 0.0010
416 FUNGAL INFECTION 34 0.0010
417 ACUTE MYOCARDIAL INFARCTION 30 0.0010
418 BRADYKINESIA 6 0.0010
419 GLUCOSE TOLERANCE IMPAIRED 6 0.0010
420 CATARACT OPERATION 6 0.0010
421 PULMONARY MASS 15 0.0010
422 FORMICATION 7 0.0010
423 GASTROINTESTINAL INFECTION 9 0.0010
424 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 5 0.0010
425 VERTIGO 61 0.0010
426 OVARIAN CYST 10 0.0010
427 BRAIN INJURY 10 0.0010
428 MUSCULAR WEAKNESS 113 0.0010
429 SEASONAL ALLERGY 14 0.0010
430 RASH PAPULAR 22 0.0010
431 HEPATITIS 25 0.0010
432 GLOMERULAR FILTRATION RATE DECREASED 12 0.0010
433 COLITIS 37 0.0010
434 IRON DEFICIENCY ANAEMIA 9 0.0010
435 CACHEXIA 5 0.0010
436 BLOOD BILIRUBIN INCREASED 26 0.0010
437 SECOND PRIMARY MALIGNANCY 8 0.0010
438 UVEITIS 13 0.0010
439 GAIT DISTURBANCE 183 0.0010
440 CYSTITIS 30 0.0009
441 PREMATURE DELIVERY 15 0.0009
442 COLON CANCER 14 0.0009
443 HYPOPHAGIA 24 0.0009
444 DIPLOPIA 24 0.0009
445 AUTOIMMUNE DISORDER 9 0.0009
446 PULMONARY THROMBOSIS 10 0.0009
447 HEPATITIS C 11 0.0009
448 SPINAL OSTEOARTHRITIS 8 0.0009
449 PARALYSIS 13 0.0009
450 BLADDER DISORDER 9 0.0009
451 LUNG INFILTRATION 8 0.0009
452 CONCUSSION 7 0.0009
453 VIRAL INFECTION 30 0.0009
454 EYE HAEMORRHAGE 12 0.0009
455 PERICARDITIS 15 0.0009
456 ANGIOPATHY 5 0.0009
457 POST PROCEDURAL COMPLICATION 17 0.0009
458 FURUNCLE 7 0.0009
459 CHOLECYSTITIS ACUTE 5 0.0009
460 GRANULOCYTOPENIA 5 0.0009
461 CORONARY ARTERY OCCLUSION 12 0.0009
462 BLOOD THYROID STIMULATING HORMONE INCREASED 8 0.0009
463 INTERVERTEBRAL DISC DEGENERATION 8 0.0009
464 TENDERNESS 9 0.0009
465 MOBILITY DECREASED 62 0.0009
466 METABOLIC DISORDER 5 0.0009
467 ELECTROLYTE IMBALANCE 10 0.0009
468 DRUG RESISTANCE 22 0.0009
469 FEELING OF BODY TEMPERATURE CHANGE 5 0.0009
470 PYREXIA 294 0.0008
471 PULMONARY TOXICITY 6 0.0008
472 THERAPY NON-RESPONDER 38 0.0008
473 SPINAL DISORDER 8 0.0008
474 HEMIPLEGIA 7 0.0008
475 MUSCULOSKELETAL DISORDER 16 0.0008
476 METASTASIS 6 0.0008
477 SKIN LESION 23 0.0008
478 MIGRAINE 80 0.0008
479 LUNG INFECTION 13 0.0008
480 CELLULITIS 42 0.0008
481 BLOOD POTASSIUM DECREASED 25 0.0008
482 THYROID CANCER 10 0.0008
483 SKIN PLAQUE 7 0.0008
484 HYPOAESTHESIA 124 0.0008
485 FEELING COLD 23 0.0008
486 WOUND INFECTION 9 0.0008
487 THROMBOTIC MICROANGIOPATHY 8 0.0008
488 INFLUENZA 91 0.0008
489 PHARYNGITIS 10 0.0008
490 RESPIRATORY SYNCYTIAL VIRUS INFECTION 7 0.0008
491 MUCOSAL INFLAMMATION 21 0.0008
492 RESPIRATORY FAILURE 58 0.0008
493 INFLUENZA LIKE ILLNESS 65 0.0008
494 MICTURITION URGENCY 9 0.0008
495 BREAST CANCER FEMALE 21 0.0008
496 LOCALISED INFECTION 19 0.0008
497 GALLBLADDER DISORDER 14 0.0008
498 HIP ARTHROPLASTY 12 0.0008
499 HAEMOLYTIC ANAEMIA 7 0.0008
500 SKIN REACTION 11 0.0008
501 INITIAL INSOMNIA 8 0.0008
502 DIFFUSE LARGE B-CELL LYMPHOMA 6 0.0008
503 LIVER INJURY 19 0.0008
504 APHTHOUS ULCER 6 0.0008
505 CANDIDA INFECTION 13 0.0008
506 C-REACTIVE PROTEIN INCREASED 28 0.0008
507 THERAPY PARTIAL RESPONDER 12 0.0008
508 BRAIN FOG 12 0.0008
509 NASOPHARYNGITIS 141 0.0008
510 RETINAL DETACHMENT 7 0.0008
511 HYPOGAMMAGLOBULINAEMIA 5 0.0008
512 IMMUNE SYSTEM DISORDER 10 0.0008
513 LOW BIRTH WEIGHT BABY 6 0.0008
514 LOSS OF CONSCIOUSNESS 96 0.0007
515 URINARY RETENTION 25 0.0007
516 BREAST MASS 5 0.0007
517 BRONCHIECTASIS 5 0.0007
518 NEUROTOXICITY 13 0.0007
519 SKIN LACERATION 8 0.0007
520 DISEASE PROGRESSION 87 0.0007
521 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 7 0.0007
522 EYE MOVEMENT DISORDER 5 0.0007
523 HYPERCALCAEMIA 9 0.0007
524 ACUTE RESPIRATORY FAILURE 14 0.0007
525 STAPHYLOCOCCAL INFECTION 24 0.0007
526 ATELECTASIS 7 0.0007
527 LYMPHOEDEMA 5 0.0007
528 LARGE INTESTINE POLYP 5 0.0007
529 EAR PAIN 14 0.0007
530 HYPERTRANSAMINASAEMIA 5 0.0007
531 AUTOIMMUNE HEPATITIS 5 0.0007
532 NEOPLASM PROGRESSION 25 0.0007
533 TOOTHACHE 13 0.0007
534 ALOPECIA 141 0.0007
535 OSTEOMYELITIS 13 0.0007
536 THYROID DISORDER 11 0.0007
537 HEPATOMEGALY 7 0.0007
538 CHROMATURIA 16 0.0007
539 DUODENAL ULCER 5 0.0007
540 REBOUND EFFECT 8 0.0007
541 DEPRESSED MOOD 37 0.0007
542 HAEMATOMA 18 0.0007
543 TOOTH ABSCESS 7 0.0007
544 BODY TEMPERATURE INCREASED 14 0.0007
545 SPINAL PAIN 8 0.0007
546 METASTASES TO LIVER 12 0.0007
547 PURPURA 6 0.0007
548 BLINDNESS TRANSIENT 5 0.0007
549 CEREBRAL DISORDER 5 0.0007
550 GLAUCOMA 13 0.0007
551 HERNIA 13 0.0007
552 ASTHENIA 252 0.0007
553 UNINTENDED PREGNANCY 7 0.0007
554 HYDRONEPHROSIS 5 0.0007
555 HYPOAESTHESIA ORAL 10 0.0007
556 JOINT DISLOCATION 7 0.0007
557 FULL BLOOD COUNT ABNORMAL 7 0.0007
558 CONTRAINDICATED PRODUCT ADMINISTERED 20 0.0007
559 GINGIVAL BLEEDING 9 0.0007
560 PATHOGEN RESISTANCE 6 0.0007
561 PARAESTHESIA 103 0.0007
562 SINUSITIS 67 0.0007
563 PULMONARY EMBOLISM 62 0.0007
564 SHOCK 15 0.0007
565 OVARIAN CANCER 6 0.0007
566 NERVE COMPRESSION 6 0.0006
567 SPINAL OPERATION 8 0.0006
568 SYNCOPE 64 0.0006
569 PLATELET COUNT DECREASED 68 0.0006
570 MULTIPLE ALLERGIES 5 0.0006
571 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 35 0.0006
572 TOOTH FRACTURE 7 0.0006
573 PNEUMOTHORAX 10 0.0006
574 ATRIAL FLUTTER 5 0.0006
575 DYSURIA 23 0.0006
576 SEIZURE 72 0.0006
577 DRUG ERUPTION 11 0.0006
578 MYASTHENIA GRAVIS 5 0.0006
579 FRUSTRATION TOLERANCE DECREASED 5 0.0006
580 DIZZINESS POSTURAL 6 0.0006
581 HIATUS HERNIA 8 0.0006
582 BACK DISORDER 10 0.0006
583 ANAEMIA 117 0.0006
584 MEMORY IMPAIRMENT 84 0.0006
585 BODY TEMPERATURE DECREASED 6 0.0006
586 NEOPLASM 7 0.0006
587 BRONCHITIS 45 0.0006
588 FALL 202 0.0006
589 SKIN CANCER 13 0.0006
590 HAEMORRHAGE INTRACRANIAL 9 0.0006
591 HYPOTONIA 6 0.0006
592 SKIN DISORDER 20 0.0006
593 CYTOKINE RELEASE SYNDROME 12 0.0006
594 EMPHYSEMA 6 0.0006
595 SPEECH DISORDER 31 0.0006
596 EPILEPSY 18 0.0006
597 CHOLECYSTITIS 7 0.0006
598 LUNG NEOPLASM MALIGNANT 24 0.0006
599 MUSCULOSKELETAL CHEST PAIN 9 0.0006
600 ANURIA 5 0.0006
601 EJECTION FRACTION DECREASED 9 0.0006
602 ILL-DEFINED DISORDER 35 0.0006
603 LABORATORY TEST ABNORMAL 17 0.0006
604 PETECHIAE 6 0.0006
605 WEIGHT FLUCTUATION 6 0.0006
606 APHONIA 8 0.0006
607 LOWER LIMB FRACTURE 11 0.0006
608 RENAL IMPAIRMENT 48 0.0006
609 MYALGIA 97 0.0006
610 HEAD INJURY 18 0.0006
611 SWELLING FACE 37 0.0006
612 COLD SWEAT 10 0.0006
613 GENERALISED OEDEMA 7 0.0006
614 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
615 BLINDNESS 23 0.0006
616 DIABETES MELLITUS 43 0.0006
617 OROPHARYNGEAL PAIN 52 0.0006
618 CONTUSION 54 0.0006
619 CARDIOTOXICITY 5 0.0006
620 HYPERSOMNIA 16 0.0006
621 DYSPNOEA EXERTIONAL 21 0.0006
622 SINUS DISORDER 11 0.0006
623 NEOPLASM MALIGNANT 37 0.0006
624 DEEP VEIN THROMBOSIS 36 0.0006
625 GASTROENTERITIS VIRAL 10 0.0006
626 LIMB INJURY 15 0.0006
627 NAUSEA 437 0.0006
628 EYE DISORDER 18 0.0005
629 NERVOUS SYSTEM DISORDER 17 0.0005
630 METASTASES TO CENTRAL NERVOUS SYSTEM 7 0.0005
631 UNRESPONSIVE TO STIMULI 14 0.0005
632 PLEURAL EFFUSION 33 0.0005
633 TASTE DISORDER 11 0.0005
634 HYPOXIA 19 0.0005
635 CONJUNCTIVITIS 10 0.0005
636 NODULE 7 0.0005
637 OCULAR DISCOMFORT 6 0.0005
638 BACK PAIN 124 0.0005
639 ABORTION INDUCED 5 0.0005
640 WEIGHT DECREASED 148 0.0005
641 VAGINAL HAEMORRHAGE 23 0.0005
642 GASTRIC ULCER 10 0.0005
643 NEUROPATHY PERIPHERAL 50 0.0005
644 HAEMATOCHEZIA 29 0.0005
645 MYOCARDITIS 6 0.0005
646 QUALITY OF LIFE DECREASED 7 0.0005
647 PANIC ATTACK 19 0.0005
648 JAUNDICE 14 0.0005
649 CAESAREAN SECTION 6 0.0005
650 PALLOR 14 0.0005
651 MUSCULOSKELETAL STIFFNESS 45 0.0005
652 PRODUCT USE IN UNAPPROVED INDICATION 127 0.0005
653 SEXUAL DYSFUNCTION 6 0.0005
654 POOR QUALITY SLEEP 11 0.0005
655 PERIPHERAL COLDNESS 7 0.0005
656 FEELING HOT 31 0.0005
657 PROCEDURAL PAIN 14 0.0005
658 ANAPHYLACTIC SHOCK 13 0.0005
659 RESPIRATORY TRACT CONGESTION 8 0.0005
660 MOOD SWINGS 16 0.0005
661 CARPAL TUNNEL SYNDROME 7 0.0005
662 FEELING ABNORMAL 119 0.0005
663 BLINDNESS UNILATERAL 7 0.0005
664 JOINT STIFFNESS 13 0.0005
665 RHINORRHOEA 32 0.0005
666 PRESYNCOPE 12 0.0005
667 ATRIAL FIBRILLATION 48 0.0005
668 CEREBRAL INFARCTION 12 0.0005
669 HAEMOGLOBIN DECREASED 50 0.0005
670 MENSTRUATION IRREGULAR 13 0.0005
671 DRUG LEVEL INCREASED 8 0.0005
672 COMPLICATION ASSOCIATED WITH DEVICE 7 0.0005
673 PNEUMONIA ASPIRATION 12 0.0005
674 CEREBROVASCULAR ACCIDENT 81 0.0005
675 BLOOD SODIUM DECREASED 9 0.0005
676 NASAL CONGESTION 28 0.0005
677 KNEE ARTHROPLASTY 10 0.0005
678 FOOT FRACTURE 9 0.0005
679 BLOOD URINE PRESENT 9 0.0005
680 HALLUCINATION, VISUAL 10 0.0005
681 DECREASED APPETITE 110 0.0005
682 INCONTINENCE 5 0.0005
683 HEPATIC CYTOLYSIS 6 0.0005
684 CHILLS 55 0.0005
685 GENERAL PHYSICAL HEALTH DETERIORATION 54 0.0005
686 HAEMOPTYSIS 13 0.0005
687 NIGHT SWEATS 15 0.0005
688 WOUND 13 0.0005
689 ABDOMINAL DISCOMFORT 78 0.0005
690 VISUAL IMPAIRMENT 57 0.0005
691 THROMBOSIS 37 0.0005
692 DISCOMFORT 28 0.0005
693 DEAFNESS 12 0.0005
694 RASH MACULAR 16 0.0005
695 TINNITUS 21 0.0005
696 IMPAIRED HEALING 15 0.0005
697 GASTROINTESTINAL PAIN 5 0.0005
698 HAEMATOCRIT DECREASED 9 0.0005
699 ANGINA PECTORIS 13 0.0005
700 ANKLE FRACTURE 7 0.0005
701 DENTAL CARIES 5 0.0005
702 DEHYDRATION 60 0.0004
703 HYPOTENSION 90 0.0004
704 ISCHAEMIC STROKE 8 0.0004
705 LIVER FUNCTION TEST ABNORMAL 13 0.0004
706 FULL BLOOD COUNT DECREASED 9 0.0004
707 ILLNESS 46 0.0004
708 SNEEZING 10 0.0004
709 TYPE 2 DIABETES MELLITUS 15 0.0004
710 CYANOSIS 7 0.0004
711 SINUS CONGESTION 6 0.0004
712 RASH PRURITIC 24 0.0004
713 EYE INFECTION 5 0.0004
714 MITRAL VALVE INCOMPETENCE 5 0.0004
715 DISEASE RECURRENCE 21 0.0004
716 BREAST CANCER 41 0.0004
717 TACHYCARDIA 39 0.0004
718 ABSCESS 7 0.0004
719 WEIGHT INCREASED 98 0.0004
720 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 21 0.0004
721 URTICARIA 73 0.0004
722 PANCREATITIS 23 0.0004
723 RESPIRATORY DISTRESS 12 0.0004
724 HEART RATE INCREASED 43 0.0004
725 PREMATURE BABY 13 0.0004
726 DERMATITIS 9 0.0004
727 BURNING SENSATION 30 0.0004
728 METASTASES TO BONE 7 0.0004
729 HEPATIC ENZYME INCREASED 29 0.0004
730 CONDITION AGGRAVATED 129 0.0004
731 INSOMNIA 113 0.0004
732 MUSCULOSKELETAL PAIN 22 0.0004
733 RECTAL HAEMORRHAGE 18 0.0004
734 PRODUCTIVE COUGH 20 0.0004
735 MACULAR DEGENERATION 5 0.0004
736 RASH ERYTHEMATOUS 20 0.0004
737 CARDIOGENIC SHOCK 6 0.0004
738 FAECES DISCOLOURED 9 0.0004
739 MYOCARDIAL INFARCTION 72 0.0004
740 NECK PAIN 23 0.0004
741 HAEMORRHOIDS 8 0.0004
742 BONE PAIN 24 0.0004
743 MUSCULOSKELETAL DISCOMFORT 7 0.0004
744 CARDIOMYOPATHY 6 0.0004
745 LIVER DISORDER 18 0.0004
746 MULTI-ORGAN FAILURE 7 0.0004
747 THROAT IRRITATION 18 0.0004
748 EPISTAXIS 30 0.0004
749 HEAD DISCOMFORT 7 0.0004
750 GASTRIC CANCER 10 0.0004
751 MUSCLE ATROPHY 5 0.0004
752 HAEMATEMESIS 10 0.0004
753 HYPERSENSITIVITY 73 0.0004
754 THIRST 7 0.0004
755 SKIN DISCOLOURATION 18 0.0004
756 GOUT 7 0.0004
757 EYE PAIN 22 0.0004
758 OSTEOPOROSIS 16 0.0004
759 DIZZINESS 194 0.0004
760 FEMUR FRACTURE 12 0.0004
761 OFF LABEL USE 339 0.0004
762 LEUKOCYTOSIS 7 0.0004
763 TRANSIENT ISCHAEMIC ATTACK 13 0.0004
764 RESTLESS LEGS SYNDROME 7 0.0004
765 CARDIAC DISORDER 36 0.0004
766 HYPERGLYCAEMIA 14 0.0004
767 RENAL FAILURE 51 0.0004
768 GASTROINTESTINAL HAEMORRHAGE 32 0.0004
769 ABDOMINAL PAIN 89 0.0004
770 MALIGNANT NEOPLASM PROGRESSION 39 0.0004
771 ORAL CANDIDIASIS 5 0.0004
772 MOUTH ULCERATION 8 0.0004
773 DISORIENTATION 15 0.0004
774 HEPATIC FUNCTION ABNORMAL 14 0.0004
775 HEPATIC CIRRHOSIS 7 0.0004
776 OESOPHAGEAL CARCINOMA 11 0.0004
777 FIBROMYALGIA 9 0.0004
778 PAIN IN EXTREMITY 109 0.0004
779 DYSPHAGIA 35 0.0004
780 HYPOKALAEMIA 17 0.0004
781 PALPITATIONS 43 0.0004
782 IMPAIRED GASTRIC EMPTYING 5 0.0004
783 VISION BLURRED 50 0.0004
784 CONSTIPATION 79 0.0004
785 TREATMENT FAILURE 30 0.0004
786 CHEST DISCOMFORT 37 0.0004
787 ORAL DISCOMFORT 5 0.0004
788 ABDOMINAL PAIN UPPER 74 0.0004
789 PLASMA CELL MYELOMA 14 0.0004
790 COUGH 100 0.0004
791 MENORRHAGIA 7 0.0004
792 DISABILITY 7 0.0004
793 PAIN IN JAW 10 0.0004
794 VOMITING 165 0.0004
795 CHEST PAIN 65 0.0004
796 PERIPHERAL SWELLING 54 0.0004
797 BRONCHOSPASM 5 0.0004
798 GASTRIC DISORDER 12 0.0003
799 PREGNANCY 7 0.0003
800 SKIN ULCER 9 0.0003
801 LETHARGY 20 0.0003
802 PARAESTHESIA ORAL 5 0.0003
803 FEEDING DISORDER 7 0.0003
804 ANAPHYLACTIC REACTION 19 0.0003
805 RENAL DISORDER 16 0.0003
806 BLOOD CHOLESTEROL INCREASED 16 0.0003
807 GASTRITIS 9 0.0003
808 HEART RATE DECREASED 12 0.0003
809 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 10 0.0003
810 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
811 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 24 0.0003
812 PAIN 206 0.0003
813 DIARRHOEA 216 0.0003
814 RESPIRATORY DISORDER 10 0.0003
815 BLOOD PRESSURE FLUCTUATION 8 0.0003
816 MUSCLE SPASMS 61 0.0003
817 PNEUMONITIS 9 0.0003
818 INTERSTITIAL LUNG DISEASE 16 0.0003
819 PELVIC PAIN 6 0.0003
820 RASH 143 0.0003
821 JOINT INJURY 7 0.0003
822 MALAISE 143 0.0003
823 DELUSION 5 0.0003
824 AGEUSIA 8 0.0003
825 OEDEMA PERIPHERAL 39 0.0003
826 ABDOMINAL PAIN LOWER 8 0.0003
827 HYPERTENSION 67 0.0003
828 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
829 ARTHRALGIA 130 0.0003
830 GASTROINTESTINAL DISORDER 28 0.0003
831 CHOLESTASIS 6 0.0003
832 POLLAKIURIA 13 0.0003
833 SLEEP DISORDER 22 0.0003
834 PANCREATIC CARCINOMA 9 0.0003
835 ERECTILE DYSFUNCTION 8 0.0003
836 PANCREATITIS ACUTE 7 0.0003
837 HEART RATE IRREGULAR 7 0.0003
838 DYSSTASIA 9 0.0003
839 BLOOD POTASSIUM INCREASED 5 0.0003
840 DYSPHONIA 18 0.0003
841 CHOKING 6 0.0003
842 SKIN BURNING SENSATION 22 0.0003
843 PSYCHOTIC DISORDER 9 0.0003
844 MUSCLE TWITCHING 7 0.0003
845 INFUSION RELATED REACTION 20 0.0003
846 RESTLESSNESS 11 0.0003
847 MENTAL DISORDER 13 0.0003
848 BLOOD UREA INCREASED 5 0.0003
849 GASTROOESOPHAGEAL REFLUX DISEASE 24 0.0003
850 EMOTIONAL DISORDER 9 0.0003
851 RIB FRACTURE 6 0.0003
852 INFLAMMATION 15 0.0003
853 MENTAL IMPAIRMENT 7 0.0003
854 MENTAL STATUS CHANGES 8 0.0003
855 CARDIAC FAILURE 23 0.0003
856 RETCHING 6 0.0003
857 IMPAIRED WORK ABILITY 6 0.0003
858 DRY EYE 14 0.0003
859 THERAPEUTIC RESPONSE DECREASED 17 0.0003
860 IRRITABLE BOWEL SYNDROME 6 0.0003
861 DISTURBANCE IN ATTENTION 15 0.0003
862 CRYING 10 0.0003
863 BLOOD PRESSURE INCREASED 42 0.0003
864 DYSPEPSIA 27 0.0003
865 INTENTIONAL PRODUCT USE ISSUE 24 0.0003
866 PRURITUS 105 0.0003
867 ANGIOEDEMA 12 0.0003
868 SOMNOLENCE 54 0.0003
869 MIDDLE INSOMNIA 5 0.0003
870 TREMOR 44 0.0003
871 CORONARY ARTERY DISEASE 8 0.0003
872 HYPOCALCAEMIA 5 0.0003
873 STOMATITIS 16 0.0003
874 DEPRESSION 60 0.0003
875 ROAD TRAFFIC ACCIDENT 11 0.0003
876 DRUG INTOLERANCE 25 0.0003
877 RHEUMATOID ARTHRITIS 29 0.0003
878 ERYTHEMA 52 0.0003
879 ARTHROPATHY 14 0.0003
880 IRRITABILITY 15 0.0002
881 DYSPNOEA 141 0.0002
882 HIP FRACTURE 8 0.0002
883 PROSTATE CANCER 20 0.0002
884 ACUTE KIDNEY INJURY 38 0.0002
885 ANXIETY 70 0.0002
886 PULMONARY OEDEMA 11 0.0002
887 ENCEPHALOPATHY 6 0.0002
888 OSTEONECROSIS 8 0.0002
889 EYE SWELLING 9 0.0002
890 DRUG INTERACTION 38 0.0002
891 ABDOMINAL DISTENSION 25 0.0002
892 ANGER 8 0.0002
893 CARDIOVASCULAR DISORDER 6 0.0002
894 DRUG INEFFECTIVE 309 0.0002
895 LACRIMATION INCREASED 7 0.0002
896 BLOOD CREATININE INCREASED 15 0.0002
897 BLOOD GLUCOSE INCREASED 43 0.0002
898 BRADYCARDIA 12 0.0002
899 FLUSHING 23 0.0002
900 SKIN EXFOLIATION 19 0.0002
901 LUNG DISORDER 11 0.0002
902 MATERNAL EXPOSURE DURING PREGNANCY 20 0.0002
903 SWELLING 21 0.0002
904 CEREBRAL HAEMORRHAGE 8 0.0002
905 ELECTROCARDIOGRAM QT PROLONGED 8 0.0002
906 THROAT TIGHTNESS 6 0.0002
907 LACTIC ACIDOSIS 7 0.0002
908 DYSGEUSIA 16 0.0002
909 OXYGEN SATURATION DECREASED 12 0.0002
910 INTESTINAL OBSTRUCTION 8 0.0002
911 BLOOD PRESSURE DECREASED 14 0.0002
912 COMA 10 0.0002
913 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
914 BLOOD GLUCOSE DECREASED 10 0.0002
915 CONFUSIONAL STATE 33 0.0002
916 ASCITES 6 0.0002
917 HYPERHIDROSIS 26 0.0002
918 HAEMORRHAGE 21 0.0002
919 DEATH 173 0.0002
920 HYPERKALAEMIA 7 0.0002
921 ACNE 15 0.0002
922 SYSTEMIC LUPUS ERYTHEMATOSUS 7 0.0002
923 PRODUCT USE ISSUE 37 0.0002
924 DYSKINESIA 8 0.0002
925 FLUID RETENTION 10 0.0002
926 BLISTER 11 0.0002
927 INCORRECT ROUTE OF DRUG ADMINISTRATION 7 0.0002
928 ASTHMA 22 0.0002
929 EXPOSURE DURING PREGNANCY 12 0.0002
930 NERVOUSNESS 10 0.0002
931 MOVEMENT DISORDER 6 0.0002
932 BLADDER CANCER 11 0.0002
933 HYPOACUSIS 8 0.0002
934 PAIN OF SKIN 5 0.0002
935 DRY MOUTH 15 0.0002
936 OEDEMA 10 0.0002
937 MOOD ALTERED 5 0.0002
938 CARDIAC ARREST 15 0.0002
939 ABNORMAL DREAMS 5 0.0002
940 LIP SWELLING 6 0.0002
941 COLITIS ULCERATIVE 8 0.0002
942 EYE PRURITUS 6 0.0002
943 HAEMATURIA 6 0.0002
944 HOT FLUSH 13 0.0002
945 PSORIATIC ARTHROPATHY 7 0.0002
946 ECZEMA 9 0.0002
947 ARRHYTHMIA 8 0.0002
948 ARTHRITIS 13 0.0002
949 ACCIDENTAL OVERDOSE 6 0.0002
950 BONE DENSITY DECREASED 5 0.0002
951 FLATULENCE 9 0.0002
952 ADVERSE DRUG REACTION 14 0.0002
953 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 8 0.0002
954 SUICIDAL IDEATION 14 0.0002
955 SKIN IRRITATION 7 0.0002
956 ABNORMAL BEHAVIOUR 6 0.0002
957 CARDIAC FAILURE CONGESTIVE 12 0.0001
958 JOINT SWELLING 18 0.0001
959 HALLUCINATION 11 0.0001
960 DELIRIUM 5 0.0001
961 HOSPITALISATION 21 0.0001
962 SURGERY 8 0.0001
963 DRY SKIN 18 0.0001
964 OCULAR HYPERAEMIA 6 0.0001
965 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
966 THERAPY INTERRUPTED 9 0.0001
967 INTENTIONAL PRODUCT MISUSE 11 0.0001
968 AMNESIA 8 0.0001
969 CARDIO-RESPIRATORY ARREST 5 0.0001
970 CATARACT 7 0.0001
971 DEVICE DISLOCATION 5 0.0001
972 TREATMENT NONCOMPLIANCE 6 0.0001
973 AGITATION 8 0.0001
974 TOXICITY TO VARIOUS AGENTS 18 0.0001
975 HYPONATRAEMIA 6 0.0001
976 HYPOGLYCAEMIA 5 0.0001
977 WHEEZING 6 0.0001
978 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 18 0.0001
979 ADVERSE EVENT 9 0.0001
980 COMPLETED SUICIDE 8 0.0001
981 UNEVALUABLE EVENT 7 0.0001
982 NO ADVERSE EVENT 14 0.0001
983 PSORIASIS 10 0.0001
984 INJECTION SITE SWELLING 5 0.0001
985 INCORRECT DOSE ADMINISTERED 14 0.0001
986 OVERDOSE 12 0.0001
987 DRUG DEPENDENCE 8 0.0000
988 EMOTIONAL DISTRESS 6 0.0000
989 PRODUCT DOSE OMISSION ISSUE 14 0.0000
990 INJECTION SITE PAIN 13 0.0000